scispace - formally typeset
J

Juan Jovel

Researcher at University of Alberta

Publications -  69
Citations -  3078

Juan Jovel is an academic researcher from University of Alberta. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 20, co-authored 58 publications receiving 2235 citations. Previous affiliations of Juan Jovel include National Autonomous University of Nicaragua & Agriculture and Agri-Food Canada.

Papers
More filters
Journal ArticleDOI

Characterization of the Gut Microbiome Using 16S or Shotgun Metagenomics.

TL;DR: The two main approaches for analyzing the microbiome, 16S ribosomal RNA gene amplicons and shotgun metagenomics, are illustrated with analyses of libraries designed to highlight their strengths and weaknesses and several methods for taxonomic classification of bacterial sequences are discussed.
Journal ArticleDOI

The 21-Nucleotide, but Not 22-Nucleotide, Viral Secondary Small Interfering RNAs Direct Potent Antiviral Defense by Two Cooperative Argonautes in Arabidopsis thaliana

TL;DR: This work identifies cooperative action of ARGONAUTE1 and ARGonAUTE2 in virus resistance conferred by 21-nucleotide virus-derived small interfering RNAs (siRNAs) and reveals that 22- nucleotide viral siRNAs do not guide efficient antiviral defense, demonstrating a qualitative difference between 21- and 22-Nucleotide classes ofSiRNAs in RNA silencing.
Journal ArticleDOI

Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis

TL;DR: An underlying defect in the UC-afflicted intestinal tract even in the absence of inflammation is suggested, implicating barrier and microbial changes as primary abnormalities in UC that may play a causative role in disease development.
Journal ArticleDOI

Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases

TL;DR: Using IgG as a marker of pathobionts in larger patient cohorts to identify microbes and elucidate their role in IBD pathogenesis will potentially underpin new strategies to facilitate development of novel, targeted diagnostic, and therapeutic approaches.